InClin, Inc
InClin is a full-service Contract Research Organization (CRO) with regional and global capabilities, providing comprehensive clinical trial management and research services from Phase 1 through Phase 4. Established in 1998, it has offices in San Mateo, California, and Sydney, Australia. The company is dedicated to developing innovative therapies and has a mission to conduct sponsor-focused trials with a collaborative approach. InClin offers a wide range of services including project management, clinical monitoring, data management, biostatistics, medical writing, drug safety, quality assurance, and strategic consulting. It has celebrated milestones such as its 20th and 25th anniversaries, and has been involved in pioneering virtual inspections with the European Medicines Agency. The company emphasizes partnerships, regulatory compliance, and innovation in clinical research.
Industries
Nr. of Employees
medium (51-250)
InClin, Inc
San Mateo, California, United States, North America
Services
Consulting on study planning, protocol design, and program optimization for clinical development.
GCP-focused QA services, inspection readiness gap assessments, TMF/ISF oversight and risk mitigation consulting.
Safety operations and pharmacovigilance services for investigational products during clinical research.
Preparation of clinical study documentation and regulatory submissions to meet timelines and quality expectations.
Integrated project management and operational oversight for clinical studies, including site and contract management.
On-study monitoring to ensure protocol adherence, data integrity and participant safety.
Consulting on study planning, protocol design, and program optimization for clinical development.
GCP-focused QA services, inspection readiness gap assessments, TMF/ISF oversight and risk mitigation consulting.
Safety operations and pharmacovigilance services for investigational products during clinical research.
Preparation of clinical study documentation and regulatory submissions to meet timelines and quality expectations.
Integrated project management and operational oversight for clinical studies, including site and contract management.
On-study monitoring to ensure protocol adherence, data integrity and participant safety.
Expertise Areas
- Clinical trial management (Phase 1–4)
- Biometrics and statistical programming
- Clinical data management
- Pharmacovigilance and drug safety
Key Technologies
- Statistical analysis and programming
- Clinical data management systems
- Trial Master File (TMF) management tools
- Pharmacovigilance and safety monitoring processes
News & Updates
InClin announced its 25th anniversary in 2023, highlighting its growth and commitment to high-quality clinical trial services since its founding in 1998.
InClin published a manuscript in Quasar about a successful fully virtual EMA inspection, demonstrating innovation in regulatory processes during COVID-19.
InClin appointed Tara Weihmiller as Vice President of Clinical Operations, with over 20 years of experience in CRO, biotech, and pharma industries.
InClin celebrated 20 years of operation and announced the opening of a new office in North Sydney, Australia.
InClin announced the relocation of its headquarters to a new address in San Mateo, CA, to support continued growth.
InClin’s Vice President of Quality, Tony Cruz, contributed to a GCP publication by Barnett International, emphasizing regulatory expertise.
InClin announced its 25th anniversary in 2023, highlighting its growth and commitment to high-quality clinical trial services since its founding in 1998.
InClin published a manuscript in Quasar about a successful fully virtual EMA inspection, demonstrating innovation in regulatory processes during COVID-19.
InClin appointed Tara Weihmiller as Vice President of Clinical Operations, with over 20 years of experience in CRO, biotech, and pharma industries.
InClin celebrated 20 years of operation and announced the opening of a new office in North Sydney, Australia.
InClin announced the relocation of its headquarters to a new address in San Mateo, CA, to support continued growth.
InClin’s Vice President of Quality, Tony Cruz, contributed to a GCP publication by Barnett International, emphasizing regulatory expertise.